Gary Albert is an accomplished medical writing leader with extensive experience in the pharmaceutical and biotech industries. Currently serving as Vice President and Head of Global Medical Writing and Clinical Trial Transparency at NOVAVAX INC since April 2020, Gary has previously held senior roles at PROMETIC BIOTHERAPEUTICS LTD and MedImmune, where significant contributions included managing medical writing functions across various therapeutic areas and complying with regulatory standards. With a foundational career beginning at U.S. Bioscience, Inc. and Wyeth-Ayerst Laboratories, Gary has developed a robust skill set in clinical documentation, protocol design, and clinical trial transparency initiatives. Educational qualifications include a Master of Science in Biology from the University of Maryland Baltimore County and a Bachelor of Science in Biology from Albright College.
This person is not in any teams
This person is not in any offices